AKT1 and cardiomyopathy: The results of the protein expression of these markers in concert with the assessment of cardiac function suggested that DAPA lessens the Dox-induced cardiomyopathy through its anti-fibrosis and anti-inflammatory effects mediated by the PI3K/AKT/Nrf2 cascade.